Literature DB >> 10665832

New approaches to rational drug design.

G K Farber1.   

Abstract

Rational drug design has emerged as a powerful technique. In this review, three new developments in rational drug design are explored. These developments include new methods to find binding sites for small molecules on the surface of a protein, the suggestion that the protein environment may change the shape of a protein sufficiently to alter drug design, and the use of data emerging from structural genomics in drug design. Although these are three new and distinct areas, the insights derived from these studies suggest a reason for the observation that similar drugs do not always bind to a protein in the same manner.

Mesh:

Substances:

Year:  1999        PMID: 10665832     DOI: 10.1016/s0163-7258(99)00039-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  3 in total

1.  Combinatorial computational method gives new picomolar ligands for a known enzyme.

Authors:  Bartosz A Grzybowski; Alexey V Ishchenko; Chu-Young Kim; George Topalov; Robert Chapman; David W Christianson; George M Whitesides; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds.

Authors:  Homa Azizian; Farzaneh Nabati; Amirhossein Sharifi; Farideh Siavoshi; Mohammad Mahdavi; Massoud Amanlou
Journal:  J Mol Model       Date:  2011-12-03       Impact factor: 1.810

3.  Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imaging.

Authors:  Rüdiger Pipkorn; Manfred Wiessler; Waldemar Waldeck; Ute Hennrich; Kiyoshi Nokihara; Marcel Beining; Klaus Braun
Journal:  Int J Med Sci       Date:  2011-11-05       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.